Anders Kjellman

718 total citations
35 papers, 440 citations indexed

About

Anders Kjellman is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Anders Kjellman has authored 35 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 15 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Anders Kjellman's work include Testicular diseases and treatments (11 papers), Prostate Cancer Treatment and Research (8 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Anders Kjellman is often cited by papers focused on Testicular diseases and treatments (11 papers), Prostate Cancer Treatment and Research (8 papers) and Prostate Cancer Diagnosis and Treatment (7 papers). Anders Kjellman collaborates with scholars based in Sweden, Norway and United States. Anders Kjellman's co-authors include Ove Gustafsson, Olof Akre, Ulf Norming, Magnus Törnblom, Hege Sagstuen Haugnes, Ása Karlsdóttir, Gabriella Cohn‐Cedermark, Ulf Håkansson, Torgrim Tandstad and Rolf Wahlqvist and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Anders Kjellman

33 papers receiving 431 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Kjellman Sweden 12 232 201 111 90 85 35 440
M.K. Gospodarowicz Canada 9 429 1.8× 120 0.6× 102 0.9× 137 1.5× 82 1.0× 15 583
Květoslava Michalová Czechia 13 284 1.2× 134 0.7× 108 1.0× 145 1.6× 145 1.7× 54 483
Laura A. Harney United States 10 265 1.1× 447 2.2× 48 0.4× 46 0.5× 108 1.3× 17 633
Juan B. Laforga Spain 13 92 0.4× 165 0.8× 103 0.9× 66 0.7× 58 0.7× 70 425
Pankhuri Wanjari United States 15 243 1.0× 64 0.3× 65 0.6× 55 0.6× 172 2.0× 35 467
Olfa Derbel France 10 211 0.9× 73 0.4× 209 1.9× 107 1.2× 36 0.4× 24 403
Toyofusa Tobe Japan 14 235 1.0× 191 1.0× 112 1.0× 34 0.4× 120 1.4× 47 469
Hiroyuki Hiraki Japan 10 171 0.7× 68 0.3× 97 0.9× 40 0.4× 109 1.3× 15 372
Zike Qin China 14 157 0.7× 291 1.4× 205 1.8× 87 1.0× 165 1.9× 55 603
Arkadius Kocot Germany 12 95 0.4× 234 1.2× 34 0.3× 51 0.6× 95 1.1× 32 427

Countries citing papers authored by Anders Kjellman

Since Specialization
Citations

This map shows the geographic impact of Anders Kjellman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Kjellman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Kjellman more than expected).

Fields of papers citing papers by Anders Kjellman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Kjellman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Kjellman. The network helps show where Anders Kjellman may publish in the future.

Co-authorship network of co-authors of Anders Kjellman

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Kjellman. A scholar is included among the top collaborators of Anders Kjellman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Kjellman. Anders Kjellman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Heidenreich, Axel, Siamak Daneshmand, Pia Paffenholz, et al.. (2024). Post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for metastatic pure seminoma.. Journal of Clinical Oncology. 42(16_suppl). 5037–5037.
2.
Gerdtsson, Axel, Helene F. S. Negaard, Ingrid Glimelius, et al.. (2024). Initial surveillance in men with marker negative clinical stage IIA non‐seminomatous germ cell tumours. British Journal of Urology. 133(6). 717–724. 1 indexed citations
3.
Haugnes, Hege Sagstuen, Torgrim Tandstad, Olof Akre, et al.. (2024). miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study. The Journal of Urology. 212(5). 720–730. 4 indexed citations
4.
Kjellman, Anders, et al.. (2024). Ablative or Surgical Treatment for Small Renal Masses (T1a): A Single-Center Comparison of Perioperative Morbidity and Complications. Current Oncology. 31(2). 933–940. 2 indexed citations
5.
Bogdanović, Darko, Kamran Mahmutyazıcıoğlu, Sam Ghazi, et al.. (2023). Autoimmune Pancreatitis Type 1 with Biliary, Nasal, Testicular, and Pulmonary Involvement: A Case Report and a Systematic Review. Journal of Clinical Medicine. 12(19). 6340–6340. 2 indexed citations
6.
Vujasinović, Miroslav, et al.. (2023). Pancreatic exocrine insufficiency is a risk factor for kidney stones in patients with chronic pancreatitis. Pancreatology. 23(3). 294–298. 2 indexed citations
7.
Tribukait, Bernhard, et al.. (2023). Prediction of Overall Survival by Thymidine Kinase 1 Combined with Prostate-Specific Antigen in Men with Prostate Cancer. International Journal of Molecular Sciences. 24(6). 5160–5160. 4 indexed citations
8.
Gerdtsson, Axel, Gustav Torisson, Ulf Håkansson, et al.. (2023). Validation of a prediction model for post‐chemotherapy fibrosis in nonseminoma patients. British Journal of Urology. 132(3). 329–336. 2 indexed citations
9.
Stattin, Pär, Marcus Westerberg, Ingela Franck Lissbrant, et al.. (2022). Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden. Clinical Genitourinary Cancer. 21(1). 107.e1–107.e9. 11 indexed citations
10.
Lindskog, Magnus, Anna Laurell, Anders Kjellman, et al.. (2022). Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study. European Urology Open Science. 40. 38–45. 8 indexed citations
11.
12.
Lindskog, Magnus, Anna Laurell, Anders Kjellman, et al.. (2020). A randomized phase II study with ilixadencel, a cell-based immune primer, plus sunitinib versus sunitinib alone in synchronous metastatic renal cell carcinoma.. Journal of Clinical Oncology. 38(5_suppl). 11–11. 11 indexed citations
13.
Tainio, Risto, et al.. (2019). Disruptive innovations and the challenges for banking. 2(3). 232–232.
14.
Gerdtsson, Axel, Ulf Håkansson, Magnus Törnblom, et al.. (2019). Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group. European Urology Oncology. 3(3). 382–389. 36 indexed citations
15.
16.
17.
Tandstad, Torgrim, Arne Solberg, Ulf Håkansson, et al.. (2014). Bilateral testicular germ cell tumors in patients treated for clinical stage I non-seminoma within two risk-adapted SWENOTECA protocols. Acta Oncologica. 54(4). 493–499. 7 indexed citations
18.
Kjellman, Anders, Søren Friis, Fredrik Granath, et al.. (2012). Treatment with finasteride and prostate cancer survival. Scandinavian Journal of Urology. 47(4). 265–271. 11 indexed citations
19.
Kjellman, Anders, Olof Akre, Oskar Gustafsson, et al.. (2010). Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening. Journal of Internal Medicine. 269(3). 299–305. 31 indexed citations
20.
Kjellman, Anders, Olof Akre, Ulf Norming, Magnus Törnblom, & Ove Gustafsson. (2007). Dihydrotestosterone Levels and Survival in Screening-Detected Prostate Cancer: A 15-yr Follow-up Study. European Urology. 53(1). 106–111. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.K. Gospodarowicz Breakdown of academic impact, for papers by Květoslava Michalová Breakdown of academic impact, for papers by Laura A. Harney Breakdown of academic impact, for papers by Juan B. Laforga Breakdown of academic impact, for papers by Pankhuri Wanjari Breakdown of academic impact, for papers by Olfa Derbel Breakdown of academic impact, for papers by Toyofusa Tobe Breakdown of academic impact, for papers by Hiroyuki Hiraki Breakdown of academic impact, for papers by Zike Qin Breakdown of academic impact, for papers by Arkadius Kocot
Rankless by CCL
2026